A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing
5/17/2013
More...
|
Successful Phase One Demonstrates Tumor Response With Increased Overall Survival for Lead VBL Therapeutics Compound in Cancer
5/16/2013
More...
|
Theravalues Release: A Clinical Study Shows the Theracurmin®'s Safety and Potential Role in Improving Quality of Life (QOL) of Pancreatic Cancer Patients
5/10/2013
More...
|
Patrys Limited (PAB.AX) Release: PAT-SM6 Kills Human Multiple Myeloma Cells
5/8/2013
More...
|
Imperial Innovations' Cell Medica Treats First Paediatricpatient in Clinical Trial of Cytovir ADV
5/8/2013
More...
|
Patrys Limited (PAB.AX) Progresses Multiple Myeloma Clinical Trial to Third Patient Group
4/24/2013
More...
|
Addex Therapeutics (ADXN.SW) Receives Approval to Initiate a Phase 1, First-In-Man, Clinical Study for ADX71441
4/24/2013
More...
|
Patrys Limited (PAB.AX) Release: New Data Strengthens PAT-SM6 Profile as an Anti-Cancer Treatment
4/22/2013
More...
|
Karolinska Development AB: Pergamum Announces Last Visit of Last Patient in a Phase I/II Trial of a Potential New Treatment for Hard-to-Heal Wounds
4/19/2013
More...
|
BioInvent (BOVNF) Release: Preclinical Data Published in Cancer Cell Highlight Novel Antibody BI-505 and Potent Anti-Myeloma Activity
4/16/2013
More...
|
Genentech (RHHBY)'s Immune Therapy Cancer Drug Shows Promise in Early Study
4/12/2013
More...
|
Patrys Limited (PAB.AX) Completes Treatment of Second Patient Group in Multiple Myeloma Trial
4/10/2013
More...
|
SAGE Therapeutics' Refractory Status Epilepticus Program Demonstrates Efficacy in First-in-Man Experience; Case Study to be Highlighted at International SE Meeting
4/4/2013
More...
|
Protalix Biotherapeutics, Inc. (PLX) Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease
4/2/2013
More...
|
Agenix Limited to File for Clinical Trial of Hepatitis B Drug by June
4/1/2013
More...
|
Curie-Cancer Trebles Number of Early Phase Clinical Research Studies With Industry Partners
3/26/2013
More...
|
Daval International Limited CSO Presents Results From an Exploratory Clinical Trial of AIMSPRO in Amyotrophic Lateral Sclerosis (ALS) at American Academy of Neurology Annual Meeting
3/21/2013
More...
|
Vince & Associates Clinical Research Sponsors the 14th Annual Phase I & IIa Clinical Trials Conference in London
3/19/2013
More...
|
Scancell Welcomes New Study in The Journal of Clinical Investigation Suggesting That Melanoma Switches Off the Immune System
3/14/2013
More...
|
BrainStorm Cell Therapeutics Inc. Presents Breakthrough Phase I/II ALS Clinical Data at the American Academy of Neurology Annual Meeting
3/13/2013
More...
|
Patrys Limited (PAB.AX) Release: Data From 1st Cohort of Patients in Multiple Myeloma Clinical Trial
3/7/2013
More...
|
InnaVirVax Announces Presentation of the Results of Its Phase I/IIa Clinical Study at CROI 2013 in Atlanta
3/5/2013
More...
|
Polyphor Reports Successful Phase I Results for Its Pseudomonas Selective Antibiotic POL7080
3/4/2013
More...
|
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Hail Results of Dermatitis Study
3/4/2013
More...
|
PROMETHERA Biosciences S.A./N.V. Opens the French Part of Its Clinical Trial in Cell Therapy
2/28/2013
More...
|
Quinten Identifies a Combination of Two Synergistic Markers That Predicts a Favorable Response to Treatment in Triple-Negative Breast Cancer
2/25/2013
More...
|
Gamida Cell Ltd.'s NiCord® Demonstrates Successful Engraftment in Patients With Hematological Malignancies in Phase I/II Study
2/15/2013
More...
|
Clasado Announces Positive Results of Clinical Study of Bimuno® for Metabolic Syndrome
2/15/2013
More...
|
Dompe Release: The First Patient Has Been Enrolled in the First International Clinical Trial of rhNGF for the Treatment of Neurotrophic Keratitis
2/14/2013
More...
|
VAXIMM Study Meets Endpoints in Phase 1/2
2/7/2013
More...
|
Genethon Receives Approval From the UK Medicine Regulatory Agency to Start a New Clinical Trial for an Inherited Immune Deficiency: Chronic Granulomatous Disease
2/5/2013
More...
|
OncoEthix Doses First Patient in Its Phase I Trial of OTX015, a BET Bromodomain Inhibitor for the Treatment of Hematologic Malignancies
1/31/2013
More...
|
Medgenics, Inc. Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment
1/30/2013
More...
|
Algeta Initiates New Oncology Research Program to Evaluate the Potential of a Targeted Thorium Conjugate (TTC) Based on Immunomedics, Inc. (IMMU)'s Anti-CD22 Monoclonal Antibody
1/28/2013
More...
|
BioInvent (BOVNF): Positive Results From the BI-505 Phase I Study in Multiple Myeloma
1/24/2013
More...
|
Molecular Partners AG Announces Publication of Results From a Phase I/II Clinical Trial of Its anti-VEGF DARPin MP0112 in Diabetic Macular Edema
1/17/2013
More...
|
Patrys Limited (PAB.AX) Progresses Multiple Myeloma Clinical Trial to Second Patient Group
1/15/2013
More...
|
Proteo, Inc. / Proteo Biotech AG: FDA Grants Proteo Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension
1/10/2013
More...
|
Merus Selects Clinical Candidate for the Treatment of Acute Myeloid Leukemia (AML)
1/7/2013
More...
|
Aspireo Pharmaceuticals Reports Somatoprim Phase I b Interim Data
1/7/2013
More...
|
Alkermes plc (ALKS) Expands CNS Pipeline and Announces Positive Results From Phase 1 Study of ALKS 3831, a Novel Antipsychotic Therapy for the Treatment of Schizophrenia
1/3/2013
More...
|
Kareus Therapeutics Announces Phase I Trial for Product in Alzheimer's Disease
1/3/2013
More...
|
Ironwood Pharmaceuticals Begins Phase I Trial of Investigational IW-2143 Anxiety Drug in US
12/21/2012
More...
|
Innate Pharma (IPH.PA ): Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced
12/19/2012
More...
|
Boston Therapeutics, Inc. Approved in France to Initiate a Clinical Trial With SUGARDOWN® in Patients With Type II Diabetes
12/19/2012
More...
|
e-Therapeutics plc Provides Update on Progress of ETS2101 Cancer Trials
12/18/2012
More...
|
Innate Pharma (IPH.PA ) (Euronext Paris: FR0010331421 - IPH): First Patient Treated in the EffiKIR Trial
12/17/2012
More...
|
PDC Biotech GmbH Announces Successful Clinical Phase I for Its Lead Compound PDC31
12/13/2012
More...
|
Hepatera Release: Maxwell Biotech Venture Fund’s Portfolio Company Hepatera Recruits First Patients in Phase 1b/2a Clinical Trial of Myrcludex B for HBV
12/12/2012
More...
|
Patrys Limited (PATZF.PK) Completes Treatment of First Patient Group in Multiple Myeloma Trial
12/10/2012
More...
|
Cancer Vaccine Specialist Scancell's SCIB1 Phase 1/2 Clinical Trial Reports Preliminary Evidence of Immune Response and Clinical Benefit
12/6/2012
More...
|
THERAVECTYS is Granted Authorization From the French and Belgian Regulatory Agencies to Launch a Phase I/Ii Clinical Trial for Its Anti-HIV Therapeutic Vaccine Candidate
11/30/2012
More...
|
InnaVirVax: the Phase I/IIa Clinical Study of Its VAC-3S Immunotherapeutic Vaccine in the Treatment of HIV Infection Has Achieved Its Primary Endpoint
11/30/2012
More...
|
NovImmune SA Initiates Phase I Clinical Study With First-in-Class Anti-TLR4 Monoclonal Antibody
11/28/2012
More...
|
Apitope Completes Recruitment Into Its Clinical Trial of ATX-MS-1467 in Multiple Sclerosis
11/26/2012
More...
|
Basilea Pharmaceutica (BSLN.SW) Initiates Next Phase 1 Multiple Ascending Dose Study With Antibiotic Bal30072 Active Against Multidrug-Resistant Gram-Negative Bacteria
11/26/2012
More...
|
Ethical Approval for Living Cell Technologies Ltd.'s NTCELL® Phase I Trial
11/16/2012
More...
|
Pluristem Therapeutics (PSTI) to Initiate a Phase I/II Clinical Trial in Muscle Injury
11/14/2012
More...
|
Nanobiotix: Phase I Independent Data Monitoring Committee Confirms Good Safety of NBTXR3 in the First Group of Patients With Advanced Soft Tissue Sarcoma
11/13/2012
More...
|
CellAct Pharma's Topoisomerase Inhibitor Demonstrates Success in Phase I Study Involving Adults With Heavily Pretreated Solid Tumors
11/12/2012
More...
|
MorphoSys AG Reports Successful Phase 1 Study of MOR103 Using a Subcutaneous Administration
11/12/2012
More...
|
Pluristem Therapeutics (PSTI) Reveals Second Patient Death
11/9/2012
More...
|
Girl Dies as Pluristem Therapeutics (PSTI) Sells on Gains With Miracle Cells
11/9/2012
More...
|
Lophius Biosciences GmbH Achieves First Clinical Proof of Principle for T-Track® TB for Detection of Active Tuberculosis and Receives Research Funding
11/8/2012
More...
|
Patrys Limited (PATZF.PK) Enrolls First Patient in Multiple Myeloma Trial
11/7/2012
More...
|
Summit Corporation Release: Repeat Dosing of SMT C1100 for Treatment of Duchenne Muscular Dystrophy Meets Endpoints in Phase 1 Clinical Trial
11/7/2012
More...
|
Senz Oncology Initiates VAL-1000 Clinical Trial in Patients With Acute Leukemias
11/7/2012
More...
|
MorphoSys AG to Present Clinical Data on MOR103 at 2012 American College of Rheumatology Annual Meeting
11/6/2012
More...
|
MorphoSys AG and Xencor Report Clinical Data for MOR208/XmAb5574
11/5/2012
More...
|
Galapagos NV (GLPG.BR) Initiates Second Phase I Study With GLPG0974
10/24/2012
More...
|
TxCell Announces Publication of CATS1 Study Results for Antigen-Specific Treg Therapy in Crohn's Disease in Gastroenterology
10/24/2012
More...
|
VAXIMM Completes Enrollment of First Oral Cancer Vaccine Trial
10/22/2012
More...
|
Legacy Healthcare Announces Breakthrough Clinical Results in Hair Re-Growth
10/22/2012
More...
|
Genticel Announces Positive Data From Its Phase I Trial in Women Infected With High-Risk HPV Before Appearance of Cervical Lesions
10/18/2012
More...
|
FAB'ENTECH Launches a Phase I Clinical Trial in Singapore for Its New Product Against H5N1 Avian Influenza
10/15/2012
More...
|
Eli Lilly and Company (LLY), Roche (RHHBY) Drugs Chosen for Alzheimer Prevention Trial
10/11/2012
More...
|
Summit Corporation Announces Positive Phase 1 Trial Results for SMT C1100 for Treatment of Duchenne Muscular Dystrophy
10/10/2012
More...
|
TiGenix Announces Publication of Cx601 Phase I/IIa Study in International Journal of Colorectal Disease
10/9/2012
More...
|
Cytheris SA Announces Publication in Blood Demonstrating CYT107 Reverses Lymphopenia and Increases Virus-Specific Immunity Post Stem Cell Transplantation
10/9/2012
More...
|
Isconova's Adjuvant Matrix-M™ in Clinical Trial With Malaria Vaccine
10/8/2012
More...
|
MorphoSys AG's Partner OncoMed Pharmaceuticals, Inc. Advances the HuCAL Antibody OMP-59R5 Into Phase 1b/2 Clinical Trial in Pancreatic Cancer
10/5/2012
More...
|
Ablynx Reports Excellent Interim Results From Phase I/II Study With Its Anti-IL-6R Nanobody, ALX-0061, in Rheumatoid Arthritis Patients
10/4/2012
More...
|
Diartis, Inc. Presents VRS-859 Positive Clinical Results for Type 2 Diabetes at 48th EASD Annual Meeting
10/2/2012
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
10/1/2012
More...
|
BioAlliance Pharma: Presentation of Phase I Clinical Results With AMEP® Biotherapy in the Treatment of Metastatic Melanoma
10/1/2012
More...
|
PsiOxus Therapeutics Limited Launches Phase I/II Clinical Trial of Oncolytic Vaccine With Dosing of Patient With Metastatic Cancer
9/26/2012
More...
|
Versartis, Inc. Phase 1 Clinical Results of Once Monthly Human Growth Hormone Presented to European Society for Paediatric Endocrinology
9/24/2012
More...
|
Patrys Limited (PATZF.PK) Receives Regulatory Approval for Multiple Myeloma Trial
9/20/2012
More...
|
MorphoSys AG's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in Rheumatoid Arthritis Patients
9/20/2012
More...
|
Gamida Cell Ltd. Completes Enrollment for Phase I/II Study of Second Pipeline Product NiCord® for Hematological Malignancies
9/19/2012
More...
|
Aprea Announces Positive Data From a Clinical Phase I/II Study With APR-246 in Patients With Advanced Cancers
9/18/2012
More...
|
Ablynx's First Inhaled Nanobody Successfully Completes Phase I Study
9/18/2012
More...
|
Critical Outcome Technologies Inc. Initiates Final Toxicity Studies for COTI-2
9/18/2012
More...
|
Immune Targeting Systems (ITS) Ltd. Announces Positive Phase I Data for Flunisyn™, Its Pan-Strain Influenza A T-Cell Vaccine, and Changes to the Company's Senior Management Team
9/17/2012
More...
|
Cytori Therapeutics, Inc. (CYTX) Release: Multicenter Investigator-Sponsored Cell Therapy Study for Peripheral Artery Disease Approved in Japan
9/13/2012
More...
|
PRANA Biotechnology (PRAN) Receives Recommendation to Proceed With Alzheimer's Clinical Trial From Data Safety Monitoring Board (DSMB)
9/12/2012
More...
|
e-Therapeutics plc Starts Second Phase I Cancer Trial of ETS2101
9/12/2012
More...
|
Cambridge Based Biotech, Phico Therapeutics, Announces Milestone in the Fight Against Multidrug Resistant Bacteria Enzyme NDM-1
9/12/2012
More...
|
Karolinska Development AB: Pergamum Announces That the First Patient has Been Dosed With Potential New Treatment for Hard-to-Heal Wounds
9/11/2012
More...
|
Oncolytic Virus Specialist Virttu Biologics Initiates Phase I/II SEPREHVIR™ Study in Mesothelioma
9/11/2012
More...
|
Generon (Shanghai) Corporation Ltd. Initiates a Phase I Clinical Study for F-652 in Australia
9/6/2012
More...
|
Pluristem Therapeutics (PSTI) Files for Orphan Drug Status With FDA for Use of PLX Cells in Treatment of Aplastic Anemia
8/30/2012
More...
|
Medgenics, Inc.' Novel Tissue Implant Approved for Two Hepatitis C Clinical Trials in Israel
8/30/2012
More...
|
Protalix Biotherapeutics, Inc. (PLX) Receives FDA IND Clearance to Initiate a Phase I/II Study of Fabry Disease Patients With PRX-102, a Modified Enzyme Replacement Therapy
8/13/2012
More...
|
Vernalis PLC (VNLPY.PK) to Present Positive Phase I Data for V158866 at 14th World Congress on Pain
8/13/2012
More...
|
Auris Medical AG Completes Enrollment in First Stage of AM-101 TACTT1 Study
8/10/2012
More...
|
ANTISENSE PHARMA GmbH Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma
7/24/2012
More...
|
BrainStorm Cell Therapeutics Inc. Reports Outstanding ALS Interim Clinical Trial Results
7/23/2012
More...
|
Pharming Group (PHGUF.PK) Confirms Safety Profile of Recombinant Human Lactoferrin in a Food Safety Study in Healthy Human Volunteers
7/16/2012
More...
|
Verona Pharma Initiates Dosing in Clinical Trial to Investigate Anti-inflammatory Properties of RPL554
7/9/2012
More...
|
MorphoSys AG Partner OncoMed Pharmaceuticals, Inc. Publishes Data on HuCAL Antibody OMP-18R5
7/5/2012
More...
|
Dramatic Change in Patient With ALS and MG Following Compassionate Use of BrainStorm Cell Therapeutics Inc.'s NurOwn™ Cell Therapy
7/3/2012
More...
|
Sosei Group Corporation Announces Successful Completion of Phase I Study for SO-1105 for the Treatment of Oropharyngeal Candidiasis
7/2/2012
More...
|
BioAlliance Pharma: Progress in the Development of Loramyc(R) in Japan Towards its Registration by the Partner Sosei Co., Ltd.
7/2/2012
More...
|
TiGenix Reports Positive Results of Cx621 Phase I
7/2/2012
More...
|
Laurantis Pharma Oy Release: Investigational Cis-urocanic Acid Eye Drops for Dry Eye Syndrome Well Tolerated, in Phase 1 Clinical Study
6/28/2012
More...
|
AEterna Zentaris (AEZS): Partner Yakult Honsha Initiates Phase 1 Trial in Multiple Myeloma With Perifosine in Japan
6/28/2012
More...
|
Celtic Pharma: Data from New Drug Trial Offers Prospect for Enhanced Quality of Life for Children With Late Stage Brain Tumors
6/27/2012
More...
|
ProtAffin AG Starts Phase 1 Study for Lead Product PA401 in Inflammatory Lung Disease
6/27/2012
More...
|
e-Therapeutics plc' ETS2101 Enters Phase I Clinical Trial in Brain Cancer
6/19/2012
More...
|
Orexo AB Successfully Completes OX219 Dose Proportionality Study Ahead of Schedule
6/19/2012
More...
|
DBV Technologies Presents Detailed Results of a Clinical Study Showing That VIASKIN® Is Safe and Well-Tolerated by Peanut-Allergic Patients at the European Academy of Allergology and Clinical Immunology Congress
6/18/2012
More...
|
DBV Technologies: Positive Interim Clinical Data in Peanut Allergic Children Treated With VIASKIN PEANUT
6/18/2012
More...
|
Summit Corporation Achieves SMT C1100 Phase 1 Dosing Milestone that Triggers Milestone Payment
6/12/2012
More...
|
Hutchison Medipharma Releases Phase I Data on Two Cancer Molecules
6/8/2012
More...
|
AFFiRiS AG Release: Parkinson's Vaccine - Worldwide First Clinical Study in Vienna
6/5/2012
More...
|
Bionor Pharma ASA Release: First Human Clinical Study of HIV Vaccine Vacc-C5 Approved to Begin
5/30/2012
More...
|
Sanofi (France) (SAN.PA) to Start China Clinical Trial of Cancer Drug In-licensed from Shanghai Institutes for Biological Sciences
5/29/2012
More...
|
Allenex AB: Tulane Starts a Prospective Trial of XM-ONE® in Kidney Transplantation
5/29/2012
More...
|
Medivir AB (MVIRb.F) Has Initiated a Phase I Clinical Trial With Its Cathepsin K inhibitor MIV-711
5/29/2012
More...
|
Summit Corporation: Summit Announces Initiation of Phase 1 Trial for the Treatment of Duchenne Muscular Dystrophy
5/25/2012
More...
|
Zytoprotec GmbH Completes Phase I/II Trial of Novel Dialysate, Enters into Negotiations With Global Pharmaceutical Company
5/23/2012
More...
|
MorphoSys AG and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL
5/22/2012
More...
|
GlaxoSmithKline (GSK)'s Melanoma Cocktail Slows Cancer in Study
5/21/2012
More...
|
Successful Phase I Study Using Isconova's Matrix MTM Adjuvant
5/14/2012
More...
|
PROMETHERA Biosciences S.A./N.V. Treats First Patients With Promethera(R) HepaStem
5/14/2012
More...
|
Mucosis B.V. Announces Positive Proof-Of-Concept Data for Mimopath® Platform in Humans
5/10/2012
More...
|
DiaGenic ASA Reports Completion of Data Collection and Genetic Analyses in a Unique Study on Familial Parkinson's Disease
5/8/2012
More...
|
Advaxis, Inc. Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ADXS-HPV for the Treatment of Head and Neck Cancer
5/8/2012
More...
|
H. Lundbeck A/S (LUN.CO) Release: Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
5/8/2012
More...
|
Probiodrug AG, Collaborators Explain Interplay of Key Suspects in Alzheimer's Disease
5/3/2012
More...
|
Karolinska Development AB: Pharmanest Initiates Phase I Trial With SHACT
4/30/2012
More...
|
Ablynx Release: Nanobody for Alzheimer's Disease From the Alliance With Boehringer Ingelheim Corporation Moves Closer Towards Phase I Clinical Trials
4/25/2012
More...
|
R-Tech Ueno: Completion of a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes
4/24/2012
More...
|
Summit Corporation Receives Regulatory Approval to Enter SMT C1100 into a Phase I Clinical Trial
4/24/2012
More...
|
QRxPharma Pty Ltd. Successfully Completes Phase 1 Studies for MoxDuo® CR
4/11/2012
More...
|
Results of Shin Nippon Biomedical Laboratories First Phase I Clinical Study for Intranasal Zolmitriptan Formulation (Migraine Drug)
4/6/2012
More...
|
Phytoceutica, Inc. of the US to Advance Clinical Trials of TCM for Cancer
4/4/2012
More...
|
Agenix Limited to File for China Clinical Trials of Hepatitis Treatment
4/2/2012
More...
|
Oncolytics Biotech Inc. (ONC.TO) Trials Show Promise of Human Virus to Treat Head and Neck Cancer Patients
4/2/2012
More...
|
e-Therapeutics plc' Phase I Clinical Trials of Cancer Drug ETS2101 Approved by Regulators
3/29/2012
More...
|
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
3/23/2012
More...
|
Rosetta Genomics Ltd. (ROSG) Study Published in International Journal of Oncology Shows Potential for microRNAs to Determine Risk of Recurrence in Colorectal Cancer
3/20/2012
More...
|
Patrys Limited (PATZF.PK) Announces Successful Phase I Clinical Trial for PAT-SM6
3/20/2012
More...
|
SuppreMol Releases Positive Interim Phase Ib/IIa Results on SM101 in Primary Immune Thrombocytopenia (ITP) Trials
3/15/2012
More...
|
InViragen Hand, Foot and Mouth Disease Vaccine Generates Immune Responses in 100% of Study Participants
3/12/2012
More...
|
Verona Pharma Appoints Manchester Clinical Research Facility to Carry Out First UK-Based Anti-Inflammatory Clinical Trial With RPL554
3/9/2012
More...
|
MorphoSys AG Completes Enrollment in MOR103 Phase 1b/2a Rheumatoid Arthritis Trial
3/6/2012
More...
|
InnaVirVax Announces the Launch of the First Clinical Trial on VAC-3S, a Novel Immunotherapy for the Treatment of HIV-1 Infections
3/5/2012
More...
|
BioTie Therapies Corp. Successfully Completes Imaging Study With SYN120
3/1/2012
More...
|
DBV Technologies Release: Clinical Development Program Receives FDA “Fast Track Designation” and Encouraging Phase Ib Safety Results for Viaskin® Peanut
2/28/2012
More...
|
Autonomic Technologies Initiates European Study of Novel Neurostimulator for the Treatment of Severe Migraine
2/27/2012
More...
|
Nuvilex Reports Encapsulated Living Cells Technology for Pancreatic Cancer Treatment Showcased in Shanghai
2/23/2012
More...
|
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
2/23/2012
More...
|
Hutchison Medipharma Starts Phase I Trial of Fourth Cancer Molecule
2/22/2012
More...
|
SK Bio-Pharmaceuticals to Initiate Phase 2 Trials in US
2/22/2012
More...
|
Genticel Completed Recruitment for Its Phase Ib Vaccine Trial in Women Infected With High-risk HPV
2/21/2012
More...
|
TxCell Presents Immuno-Monitoring Results of Its Phase I/II Clinical Trial With Antigen-Specific Treg Cells in Crohn's Disease
2/21/2012
More...
|
Ferrer Announces Best-In-Class Results in Phase I for Lorediplon in Insomnia
2/9/2012
More...
|
Patrys Limited (PATZF.PK) Release: Clinical Trial Successfully Completed in PAT-SM6 for Melanoma
2/9/2012
More...
|
DiaGenic ASA Reports High 85% Accuracy for Blood Based Diagnosis in Early Parkinson Patients in European Multicenter Study
2/8/2012
More...
|
Results from International Trial of Second Sight’s Argus® II Retinal Prosthesis System Published in Ophthalmology
2/7/2012
More...
|
Advanced Cell Technology Announces Aberdeen University Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration
2/3/2012
More...
|
REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD
2/1/2012
More...
|
European Medicines Evaluation Agency Approves Orphan Medicinal Product Application of Dcprime's Acute Myeloid Leukemia Vaccine
2/1/2012
More...
|
Alkermes plc (ALKS) Initiates Open-Label Pilot Study of VIVITROL® to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence
1/31/2012
More...
|
Active Biotech AB (BTPC)'s Prostate Cancer Project TASQ in Phase I Combination Therapy Trial
1/23/2012
More...
|
Advanced Cell Technology Announces Europe’s First Human Embryonic Stem Cell Transplant in Patient with Stargardt’s Disease
1/23/2012
More...
|
Enlivex Therapeutics Ltd. Completes Patient Enrollment in its Phase I/II Clinical Trial
1/23/2012
More...
|
BioAlliance Pharma Announces Two Key Steps with Its AMEP™ Biotherapy for Metastatic Melanoma
1/23/2012
More...
|
Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study
1/19/2012
More...
|
Sabin Vaccine Institute Release: Candidate for First Human Hookworm Vaccine Enters Phase 1 Clinical Trial in Brazil
1/19/2012
More...
|
Ceptaris Therapeutics, Inc. Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel
1/18/2012
More...
|
Rexahn Pharmaceuticals, Inc. Secures Approval in Europe to Conduct a First-in-Human Trial of RX-3117 in Solid Tumors
1/18/2012
More...
|
BrainStorm Cell Therapeutics Inc. Announces Clinical Data Supporting Safety and Efficacy of NurOwn™ Based on Initial Patient Results
1/17/2012
More...
|
Endosense Launches TactiCath® 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study
1/12/2012
More...
|
Genethon, AFM: Encouraging Results in a Phase I Clinical Trial in Limb-Girdle Muscular Dystrophy Type 2C
1/12/2012
More...
|
Recipharm AB Enables PledPharma to Re-start Myocardial Infarction Trial Following Approval from the Swedish Medical Products Agency
1/9/2012
More...
|
Alkermes plc (ALKS) Announces Positive Results From Clinical Study of ALKS 5461 for Major Depressive Disorder
1/4/2012
More...
|
AEterna Zentaris (AEZS) Partner, Yakult Honsha, Initiates Phase 1/2 Trial with Perifosine in Colorectal Cancer in Japan
1/3/2012
More...
|
Can-Fite BioPharma Announces Successful Results of its Phase I/II Liver Cancer Study with its CF102 Drug; the Study Achieved the Primary and Secondary Endpoints
1/3/2012
More...
|
Galapagos NV (GLPG.BR) Initiates Clinical Study With GLPG0974, the First Anti-inflammatory Candidate Drug Targeting GPR43
12/21/2011
More...
|
MorphoSys AG Initiates Phase 1b Clinical Trial with MOR103 in Patients with Multiple Sclerosis
12/21/2011
More...
|
Orexo AB: Positive Study Results for OX27
12/20/2011
More...
|
Planning for Patrys Limited (PATZF.PK)' Multiple Myeloma Trial Underway
12/19/2011
More...
|
VAXIMM Starts Clinical Study of First Oral Cancer Vaccine
12/13/2011
More...
|
CELLMED Research GmbH Release: First Clinical Data on the Safety of PROCURE® During Trial Phase I/IIa
12/13/2011
More...
|
Ablynx Initiates Phase I Study With ALX-0171 for the Treatment of Respiratory Syncytial Virus (RSV)
12/13/2011
More...
|
Genentech (RHHBY) Initiates First-in-Human Study with NovImmune SA's Anti-IL17 Antibody
12/13/2011
More...
|
Genmab A/S (GEN.CO) Announces Preliminary Safety and Efficacy Data for Daratumumab
12/12/2011
More...
|